Provided by Tiger Trade Technology Pte. Ltd.

Kiniksa Pharmaceuticals Ltd.

78.63
+0.55000.70%
Post-market: 78.630.00000.00%19:30 EDT
Volume:428.07K
Turnover:33.41M
Market Cap:6.14B
PE:79.42
High:78.96
Open:78.00
Low:76.65
Close:78.08
52wk High:82.94
52wk Low:33.45
Shares:78.02M
Float Shares:40.20M
Volume Ratio:1.05
T/O Rate:1.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.9900
EPS(LYR):0.7500
ROE:14.04%
ROA:8.05%
PB:9.38
PE(LYR):104.84

Loading ...

Mar 02, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 02, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 28, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 03, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 09, 2023

Major Issues Report

8-K - Current report
Nov 03, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 01, 2022

Major Issues Report

8-K - Current report
Aug 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 03, 2022

Major Issues Report

8-K - Current report
Jun 30, 2022

Major Issues Report

8-K - Current report
May 13, 2022

Correspondence

CORRESP [Cover] - Correspondence
May 13, 2022

Correspondence

CORRESP [Cover] - Correspondence
May 05, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 03, 2022

Major Issues Report

8-K - Current report
Feb 24, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 24, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 22, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals